DHIN 2025Connectathon FHIR IG
0.1.0 - draft
DHIN 2025Connectathon FHIR IG, published by DHIN. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Nigeria-FHIR-Community/2025Connectathon/ and changes regularly. See the Directory of published versions
| Active as of 2025-10-21 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="ng-atc-medication-cs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ng-atc-medication-cs</b></p><a name="ng-atc-medication-cs"> </a><a name="hcng-atc-medication-cs"> </a><p>This case-sensitive code system <code>https://sandbox.dhin-hie.org/ig/CodeSystem/ng-atc-medication-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">A11-IFA<a name="ng-atc-medication-cs-A11-IFA"> </a></td><td>Iron–Folic Acid tablets (30/0.4 mg)</td><td>Daily antenatal iron–folate for anemia prevention.</td></tr><tr><td style="white-space:nowrap">A11-FA-5<a name="ng-atc-medication-cs-A11-FA-5"> </a></td><td>Folic acid 5 mg tablet</td><td>High-dose folate per protocol.</td></tr><tr><td style="white-space:nowrap">A12-CALC<a name="ng-atc-medication-cs-A12-CALC"> </a></td><td>Calcium carbonate 500 mg tablet</td><td>Calcium supplementation to reduce pre-eclampsia risk.</td></tr><tr><td style="white-space:nowrap">B03-FE-SULF<a name="ng-atc-medication-cs-B03-FE-SULF"> </a></td><td>Ferrous sulfate 200 mg (65 mg elemental) tablet</td><td>Treatment of iron-deficiency anemia.</td></tr><tr><td style="white-space:nowrap">A11-MV-PREN<a name="ng-atc-medication-cs-A11-MV-PREN"> </a></td><td>Prenatal multivitamin</td><td>Combined antenatal vitamin/mineral tablet.</td></tr><tr><td style="white-space:nowrap">A11-VITA-100<a name="ng-atc-medication-cs-A11-VITA-100"> </a></td><td>Vitamin A 100,000 IU capsule</td><td>For post-partum/child dosing per guideline.</td></tr><tr><td style="white-space:nowrap">A11-VITA-200<a name="ng-atc-medication-cs-A11-VITA-200"> </a></td><td>Vitamin A 200,000 IU capsule</td><td>For post-partum/child dosing per guideline.</td></tr><tr><td style="white-space:nowrap">G02-OXY<a name="ng-atc-medication-cs-G02-OXY"> </a></td><td>Oxytocin 10 IU/mL injection</td><td>Active management of third stage, PPH prevention/treatment.</td></tr><tr><td style="white-space:nowrap">G02-MISO<a name="ng-atc-medication-cs-G02-MISO"> </a></td><td>Misoprostol 200 mcg tablet</td><td>PPH prevention/treatment where oxytocin unavailable.</td></tr><tr><td style="white-space:nowrap">A12-MGSO4<a name="ng-atc-medication-cs-A12-MGSO4"> </a></td><td>Magnesium sulfate injection</td><td>Severe pre-eclampsia/eclampsia management (loading/maintenance).</td></tr><tr><td style="white-space:nowrap">C02-METHYLDOPA<a name="ng-atc-medication-cs-C02-METHYLDOPA"> </a></td><td>Methyldopa 250 mg tablet</td><td>Antihypertensive in pregnancy per protocol.</td></tr><tr><td style="white-space:nowrap">C08-NIFEDIPINE<a name="ng-atc-medication-cs-C08-NIFEDIPINE"> </a></td><td>Nifedipine 10 mg capsule</td><td>Acute BP control in severe hypertension (per protocol).</td></tr><tr><td style="white-space:nowrap">J01-AMX-DT<a name="ng-atc-medication-cs-J01-AMX-DT"> </a></td><td>Amoxicillin 250 mg dispersible tablet</td><td>Child pneumonia/OTIT treatment; community case mgmt.</td></tr><tr><td style="white-space:nowrap">J01-AMOX-CAP<a name="ng-atc-medication-cs-J01-AMOX-CAP"> </a></td><td>Amoxicillin 500 mg capsule</td><td>Adult/maternal infections per protocol.</td></tr><tr><td style="white-space:nowrap">J01-AMP<a name="ng-atc-medication-cs-J01-AMP"> </a></td><td>Ampicillin injection</td><td>Neonatal sepsis first-line (with gentamicin).</td></tr><tr><td style="white-space:nowrap">J01-GENTA<a name="ng-atc-medication-cs-J01-GENTA"> </a></td><td>Gentamicin injection</td><td>Neonatal sepsis first-line (with ampicillin).</td></tr><tr><td style="white-space:nowrap">J01-CEFTRI<a name="ng-atc-medication-cs-J01-CEFTRI"> </a></td><td>Ceftriaxone injection</td><td>Severe infections; inpatient use per protocol.</td></tr><tr><td style="white-space:nowrap">J01-CLX<a name="ng-atc-medication-cs-J01-CLX"> </a></td><td>Cloxacillin 500 mg capsule</td><td>Skin/soft tissue and mastitis per protocol.</td></tr><tr><td style="white-space:nowrap">J01-METRO<a name="ng-atc-medication-cs-J01-METRO"> </a></td><td>Metronidazole 400 mg tablet</td><td>Anaerobic/obstetric infections per protocol.</td></tr><tr><td style="white-space:nowrap">J06-ANTI-D-IG<a name="ng-atc-medication-cs-J06-ANTI-D-IG"> </a></td><td>Anti-D immunoglobulin</td><td>Rh-D negative prophylaxis for sensitizing events.</td></tr><tr><td style="white-space:nowrap">J01-ERYTHRO<a name="ng-atc-medication-cs-J01-ERYTHRO"> </a></td><td>Erythromycin 250 mg tablet</td><td>Alternative macrolide; PPROM/GBS contexts per protocol.</td></tr><tr><td style="white-space:nowrap">A07-ORS<a name="ng-atc-medication-cs-A07-ORS"> </a></td><td>Oral rehydration salts (sachet)</td><td>Acute diarrhea rehydration.</td></tr><tr><td style="white-space:nowrap">A07-ZINC20<a name="ng-atc-medication-cs-A07-ZINC20"> </a></td><td>Zinc sulfate 20 mg tablet</td><td>Adjunct for pediatric diarrhea (10–14 days).</td></tr><tr><td style="white-space:nowrap">N02-PARA-SYR<a name="ng-atc-medication-cs-N02-PARA-SYR"> </a></td><td>Paracetamol 125 mg/5 mL syrup</td><td>Fever/pain management in children.</td></tr><tr><td style="white-space:nowrap">R03-SALB-INH<a name="ng-atc-medication-cs-R03-SALB-INH"> </a></td><td>Salbutamol 100 mcg inhaler</td><td>Wheeze/asthma relief in MNCH contexts.</td></tr><tr><td style="white-space:nowrap">P01-ACT-AL<a name="ng-atc-medication-cs-P01-ACT-AL"> </a></td><td>ACT: Artemether–Lumefantrine</td><td>First-line uncomplicated malaria (weight-based).</td></tr><tr><td style="white-space:nowrap">P01-ACT-DHA-PPQ<a name="ng-atc-medication-cs-P01-ACT-DHA-PPQ"> </a></td><td>ACT: Dihydroartemisinin–Piperaquine</td><td>Alternative ACT per national guideline.</td></tr><tr><td style="white-space:nowrap">P01-SP<a name="ng-atc-medication-cs-P01-SP"> </a></td><td>Sulfadoxine–Pyrimethamine (SP)</td><td>IPTp in pregnancy per schedule.</td></tr><tr><td style="white-space:nowrap">P02-ALB<a name="ng-atc-medication-cs-P02-ALB"> </a></td><td>Albendazole 400 mg tablet</td><td>Antenatal deworming per protocol.</td></tr><tr><td style="white-space:nowrap">G03-LNG-EC<a name="ng-atc-medication-cs-G03-LNG-EC"> </a></td><td>Levonorgestrel 1.5 mg (EC)</td><td>Emergency contraception (single dose).</td></tr><tr><td style="white-space:nowrap">G03-DMPA-IM<a name="ng-atc-medication-cs-G03-DMPA-IM"> </a></td><td>DMPA 150 mg/mL IM injection</td><td>3-monthly injectable contraceptive.</td></tr><tr><td style="white-space:nowrap">G03-DMPA-SC<a name="ng-atc-medication-cs-G03-DMPA-SC"> </a></td><td>DMPA 104 mg/0.65 mL SC</td><td>3-monthly SC contraceptive (sayana-type).</td></tr><tr><td style="white-space:nowrap">G03-ETON-IMP<a name="ng-atc-medication-cs-G03-ETON-IMP"> </a></td><td>Etonogestrel implant</td><td>Long-acting reversible contraception.</td></tr><tr><td style="white-space:nowrap">G03-COC<a name="ng-atc-medication-cs-G03-COC"> </a></td><td>Combined oral contraceptive (LNG/EE)</td><td>Daily combined pill per protocol.</td></tr><tr><td style="white-space:nowrap">D08-CHX-7<a name="ng-atc-medication-cs-D08-CHX-7"> </a></td><td>Chlorhexidine 7.1% digluconate gel</td><td>Umbilical cord care (4% free CHX equivalent).</td></tr><tr><td style="white-space:nowrap">J07-BCG<a name="ng-atc-medication-cs-J07-BCG"> </a></td><td>BCG vaccine</td><td>At birth — TB prevention.</td></tr><tr><td style="white-space:nowrap">J07-OPV<a name="ng-atc-medication-cs-J07-OPV"> </a></td><td>OPV vaccine</td><td>Oral polio per schedule.</td></tr><tr><td style="white-space:nowrap">J07-IPV<a name="ng-atc-medication-cs-J07-IPV"> </a></td><td>IPV vaccine</td><td>Inactivated polio per schedule.</td></tr><tr><td style="white-space:nowrap">J07-PENTA<a name="ng-atc-medication-cs-J07-PENTA"> </a></td><td>Pentavalent DTP-HepB-Hib vaccine</td><td>Primary series per schedule.</td></tr><tr><td style="white-space:nowrap">J07-PCV<a name="ng-atc-medication-cs-J07-PCV"> </a></td><td>Pneumococcal conjugate vaccine</td><td>PCV10/13 per national schedule.</td></tr><tr><td style="white-space:nowrap">J07-ROTA<a name="ng-atc-medication-cs-J07-ROTA"> </a></td><td>Rotavirus vaccine</td><td>Rotavirus per schedule.</td></tr><tr><td style="white-space:nowrap">J07-MR<a name="ng-atc-medication-cs-J07-MR"> </a></td><td>Measles-Rubella vaccine</td><td>MR at 9/15 months per schedule.</td></tr><tr><td style="white-space:nowrap">J07-YF<a name="ng-atc-medication-cs-J07-YF"> </a></td><td>Yellow fever vaccine</td><td>Yellow fever per schedule.</td></tr><tr><td style="white-space:nowrap">J07-HPV<a name="ng-atc-medication-cs-J07-HPV"> </a></td><td>HPV vaccine</td><td>Girls/boys per national program.</td></tr><tr><td style="white-space:nowrap">J07-TD<a name="ng-atc-medication-cs-J07-TD"> </a></td><td>Tetanus-diphtheria (Td) vaccine</td><td>Adolescent/maternal protection.</td></tr><tr><td style="white-space:nowrap">R01-ORS-ZINC-KIT<a name="ng-atc-medication-cs-R01-ORS-ZINC-KIT"> </a></td><td>ORS + Zinc kit</td><td>Community diarrhea pack for claims/prescription.</td></tr><tr><td style="white-space:nowrap">J01-AMP-GEN-COMB<a name="ng-atc-medication-cs-J01-AMP-GEN-COMB"> </a></td><td>Ampicillin + Gentamicin regimen (neonatal)</td><td>Combined line item for neonatal sepsis claims.</td></tr><tr><td style="white-space:nowrap">A10-INSULIN-NPH<a name="ng-atc-medication-cs-A10-INSULIN-NPH"> </a></td><td>Insulin NPH</td><td>Gestational diabetes—basal insulin per protocol.</td></tr><tr><td style="white-space:nowrap">A10-METFORMIN<a name="ng-atc-medication-cs-A10-METFORMIN"> </a></td><td>Metformin 500 mg tablet</td><td>GDM/T2DM per national guideline and obstetric advice.</td></tr></table></div>
</text>
<url
value="https://sandbox.dhin-hie.org/ig/CodeSystem/ng-atc-medication-cs"/>
<version value="0.1.0"/>
<name value="NgATCLocalMedicationCS"/>
<title value="NG Local ATC Medication Codes"/>
<status value="active"/>
<experimental value="false"/>
<date value="2025-10-21T10:55:54+00:00"/>
<publisher value="DHIN"/>
<contact>
<name value="DHIN"/>
<telecom>
<system value="url"/>
<value value="https://www.dhin-hie.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@dhin-hie.org"/>
</telecom>
</contact>
<contact>
<name value="Digital Health Interoperability Network."/>
<telecom>
<system value="email"/>
<value value="info@dhin-hie.org"/>
<use value="work"/>
</telecom>
</contact>
<description
value="Local, ATC-inspired medication codes for MNCH referral, claims, prescription, and immunization use cases at the DHIN 2025 Connectathon. Codes are placeholders aligned to common maternal, newborn, and child health needs, plus EPI vaccines."/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="49"/>
<concept>
<code value="A11-IFA"/>
<display value="Iron–Folic Acid tablets (30/0.4 mg)"/>
<definition value="Daily antenatal iron–folate for anemia prevention."/>
</concept>
<concept>
<code value="A11-FA-5"/>
<display value="Folic acid 5 mg tablet"/>
<definition value="High-dose folate per protocol."/>
</concept>
<concept>
<code value="A12-CALC"/>
<display value="Calcium carbonate 500 mg tablet"/>
<definition
value="Calcium supplementation to reduce pre-eclampsia risk."/>
</concept>
<concept>
<code value="B03-FE-SULF"/>
<display value="Ferrous sulfate 200 mg (65 mg elemental) tablet"/>
<definition value="Treatment of iron-deficiency anemia."/>
</concept>
<concept>
<code value="A11-MV-PREN"/>
<display value="Prenatal multivitamin"/>
<definition value="Combined antenatal vitamin/mineral tablet."/>
</concept>
<concept>
<code value="A11-VITA-100"/>
<display value="Vitamin A 100,000 IU capsule"/>
<definition value="For post-partum/child dosing per guideline."/>
</concept>
<concept>
<code value="A11-VITA-200"/>
<display value="Vitamin A 200,000 IU capsule"/>
<definition value="For post-partum/child dosing per guideline."/>
</concept>
<concept>
<code value="G02-OXY"/>
<display value="Oxytocin 10 IU/mL injection"/>
<definition
value="Active management of third stage, PPH prevention/treatment."/>
</concept>
<concept>
<code value="G02-MISO"/>
<display value="Misoprostol 200 mcg tablet"/>
<definition value="PPH prevention/treatment where oxytocin unavailable."/>
</concept>
<concept>
<code value="A12-MGSO4"/>
<display value="Magnesium sulfate injection"/>
<definition
value="Severe pre-eclampsia/eclampsia management (loading/maintenance)."/>
</concept>
<concept>
<code value="C02-METHYLDOPA"/>
<display value="Methyldopa 250 mg tablet"/>
<definition value="Antihypertensive in pregnancy per protocol."/>
</concept>
<concept>
<code value="C08-NIFEDIPINE"/>
<display value="Nifedipine 10 mg capsule"/>
<definition
value="Acute BP control in severe hypertension (per protocol)."/>
</concept>
<concept>
<code value="J01-AMX-DT"/>
<display value="Amoxicillin 250 mg dispersible tablet"/>
<definition value="Child pneumonia/OTIT treatment; community case mgmt."/>
</concept>
<concept>
<code value="J01-AMOX-CAP"/>
<display value="Amoxicillin 500 mg capsule"/>
<definition value="Adult/maternal infections per protocol."/>
</concept>
<concept>
<code value="J01-AMP"/>
<display value="Ampicillin injection"/>
<definition value="Neonatal sepsis first-line (with gentamicin)."/>
</concept>
<concept>
<code value="J01-GENTA"/>
<display value="Gentamicin injection"/>
<definition value="Neonatal sepsis first-line (with ampicillin)."/>
</concept>
<concept>
<code value="J01-CEFTRI"/>
<display value="Ceftriaxone injection"/>
<definition value="Severe infections; inpatient use per protocol."/>
</concept>
<concept>
<code value="J01-CLX"/>
<display value="Cloxacillin 500 mg capsule"/>
<definition value="Skin/soft tissue and mastitis per protocol."/>
</concept>
<concept>
<code value="J01-METRO"/>
<display value="Metronidazole 400 mg tablet"/>
<definition value="Anaerobic/obstetric infections per protocol."/>
</concept>
<concept>
<code value="J06-ANTI-D-IG"/>
<display value="Anti-D immunoglobulin"/>
<definition value="Rh-D negative prophylaxis for sensitizing events."/>
</concept>
<concept>
<code value="J01-ERYTHRO"/>
<display value="Erythromycin 250 mg tablet"/>
<definition
value="Alternative macrolide; PPROM/GBS contexts per protocol."/>
</concept>
<concept>
<code value="A07-ORS"/>
<display value="Oral rehydration salts (sachet)"/>
<definition value="Acute diarrhea rehydration."/>
</concept>
<concept>
<code value="A07-ZINC20"/>
<display value="Zinc sulfate 20 mg tablet"/>
<definition value="Adjunct for pediatric diarrhea (10–14 days)."/>
</concept>
<concept>
<code value="N02-PARA-SYR"/>
<display value="Paracetamol 125 mg/5 mL syrup"/>
<definition value="Fever/pain management in children."/>
</concept>
<concept>
<code value="R03-SALB-INH"/>
<display value="Salbutamol 100 mcg inhaler"/>
<definition value="Wheeze/asthma relief in MNCH contexts."/>
</concept>
<concept>
<code value="P01-ACT-AL"/>
<display value="ACT: Artemether–Lumefantrine"/>
<definition value="First-line uncomplicated malaria (weight-based)."/>
</concept>
<concept>
<code value="P01-ACT-DHA-PPQ"/>
<display value="ACT: Dihydroartemisinin–Piperaquine"/>
<definition value="Alternative ACT per national guideline."/>
</concept>
<concept>
<code value="P01-SP"/>
<display value="Sulfadoxine–Pyrimethamine (SP)"/>
<definition value="IPTp in pregnancy per schedule."/>
</concept>
<concept>
<code value="P02-ALB"/>
<display value="Albendazole 400 mg tablet"/>
<definition value="Antenatal deworming per protocol."/>
</concept>
<concept>
<code value="G03-LNG-EC"/>
<display value="Levonorgestrel 1.5 mg (EC)"/>
<definition value="Emergency contraception (single dose)."/>
</concept>
<concept>
<code value="G03-DMPA-IM"/>
<display value="DMPA 150 mg/mL IM injection"/>
<definition value="3-monthly injectable contraceptive."/>
</concept>
<concept>
<code value="G03-DMPA-SC"/>
<display value="DMPA 104 mg/0.65 mL SC"/>
<definition value="3-monthly SC contraceptive (sayana-type)."/>
</concept>
<concept>
<code value="G03-ETON-IMP"/>
<display value="Etonogestrel implant"/>
<definition value="Long-acting reversible contraception."/>
</concept>
<concept>
<code value="G03-COC"/>
<display value="Combined oral contraceptive (LNG/EE)"/>
<definition value="Daily combined pill per protocol."/>
</concept>
<concept>
<code value="D08-CHX-7"/>
<display value="Chlorhexidine 7.1% digluconate gel"/>
<definition value="Umbilical cord care (4% free CHX equivalent)."/>
</concept>
<concept>
<code value="J07-BCG"/>
<display value="BCG vaccine"/>
<definition value="At birth — TB prevention."/>
</concept>
<concept>
<code value="J07-OPV"/>
<display value="OPV vaccine"/>
<definition value="Oral polio per schedule."/>
</concept>
<concept>
<code value="J07-IPV"/>
<display value="IPV vaccine"/>
<definition value="Inactivated polio per schedule."/>
</concept>
<concept>
<code value="J07-PENTA"/>
<display value="Pentavalent DTP-HepB-Hib vaccine"/>
<definition value="Primary series per schedule."/>
</concept>
<concept>
<code value="J07-PCV"/>
<display value="Pneumococcal conjugate vaccine"/>
<definition value="PCV10/13 per national schedule."/>
</concept>
<concept>
<code value="J07-ROTA"/>
<display value="Rotavirus vaccine"/>
<definition value="Rotavirus per schedule."/>
</concept>
<concept>
<code value="J07-MR"/>
<display value="Measles-Rubella vaccine"/>
<definition value="MR at 9/15 months per schedule."/>
</concept>
<concept>
<code value="J07-YF"/>
<display value="Yellow fever vaccine"/>
<definition value="Yellow fever per schedule."/>
</concept>
<concept>
<code value="J07-HPV"/>
<display value="HPV vaccine"/>
<definition value="Girls/boys per national program."/>
</concept>
<concept>
<code value="J07-TD"/>
<display value="Tetanus-diphtheria (Td) vaccine"/>
<definition value="Adolescent/maternal protection."/>
</concept>
<concept>
<code value="R01-ORS-ZINC-KIT"/>
<display value="ORS + Zinc kit"/>
<definition value="Community diarrhea pack for claims/prescription."/>
</concept>
<concept>
<code value="J01-AMP-GEN-COMB"/>
<display value="Ampicillin + Gentamicin regimen (neonatal)"/>
<definition value="Combined line item for neonatal sepsis claims."/>
</concept>
<concept>
<code value="A10-INSULIN-NPH"/>
<display value="Insulin NPH"/>
<definition value="Gestational diabetes—basal insulin per protocol."/>
</concept>
<concept>
<code value="A10-METFORMIN"/>
<display value="Metformin 500 mg tablet"/>
<definition
value="GDM/T2DM per national guideline and obstetric advice."/>
</concept>
</CodeSystem>